| Dietary lipids, gut microbiota and lipid metabolism |
30 |
| Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle |
28 |
| Fertility preservation options in transgender people: A review |
20 |
| Quality of life of treatment-seeking transgender adults: A systematic review and meta-analysis |
16 |
| Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review |
16 |
| Gut microbiota and Hashimoto's thyroiditis |
15 |
| Thyroid disorders induced by checkpoint inhibitors |
15 |
| Prader- Willi syndrome: An uptodate on endocrine and metabolic complications |
14 |
| Gaps in transgender medical education among healthcare providers: A major barrier to care for transgender persons |
12 |
| Efficacy of radiofrequency ablation in autonomous functioning thyroid nodules. A systematic review and meta-analysis |
12 |
| Nutrition and neuroendocrine tumors: An update of the literature |
12 |
| Gut microbiota-derived succinate: Friend or foe in human metabolic diseases? |
11 |
| Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases |
11 |
| Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease |
10 |
| Innate immune cells in the adipose tissue |
10 |
| The increasing prevalence of chronic lymphocytic thyroiditis in papillary microcarcinoma |
10 |
| Keto microbiota: A powerful contributor to host disease recovery |
8 |
| Structure and function of the exocrine pancreas in patients with type 1 diabetes |
8 |
| Hepatitis C virus infection and development of type 2 diabetes mellitus: Systematic review and meta-analysis of the literature |
8 |
| Diabetic lung disease: fact or fiction? |
8 |
| The prevalence of retinopathy among type 2 diabetic patients in Iran: A systematic review and meta-analysis |
8 |
| Cardiovascular health in transgender people |
8 |
| Impact of pregnancy on inborn errors of metabolism |
7 |
| Effect of resveratrol on metabolic syndrome components: A systematic review and meta-analysis |
7 |
| Primary hypophysitis and other autoimmune disorders of the sellar and suprasellar regions |
7 |
| Thyroid diseases and skin autoimmunity |
6 |
| Microbiota impacts on chronic inflammation and metabolic syndrome-related cognitive dysfunction |
6 |
| Primary tumors of the posterior pituitary: A systematic review |
6 |
| Is endoscopic ultrasonography more sensitive than magnetic resonance imaging in detecting and localizing pancreatic neuroendocrine tumors? |
6 |
| PET/CT in thyroid nodule and differentiated thyroid cancer patients. The evidence-based state of the art |
5 |
| The gut microbiome and heart failure: A better gut for a better heart |
5 |
| The gut microbiota modulates both browning of white adipose tissue and the activity of brown adipose tissue |
5 |
| Multilayered heterogeneity as an intrinsic hallmark of neuroendocrine tumors |
5 |
| The gut microbiota to the brain axis in the metabolic control |
5 |
| Vitamin D in physiological and pathological aging: Lesson from centenarians |
5 |
| Transgender medicine - puberty suppression |
5 |
| Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties? |
5 |
| Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly |
5 |
| Myo-inositol in autoimmune thyroiditis, and hypothyroidism |
4 |
| Calcium citrate: from biochemistry and physiology to clinical applications |
4 |
| Endocrine disorders associated with hepatitis C virus chronic infection |
4 |
| Risk of vertebral fractures in hypoparathyroidism |
4 |
| Role of epigenomic mechanisms in the onset and management of insulin resistance |
4 |
| Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important |
4 |
| Bone health in patients with inborn errors of metabolism |
4 |
| The roles of FGF21 in atherosclerosis pathogenesis |
3 |
| Endocrine treatment of aging transgender people |
3 |
| Agreement between medical records and self-reports: Implications for transgender health research |
3 |
| Not quite type 1 or type what now? Review of monogenic, mitochondrial, and syndromic diabetes |
3 |
| Clinical applications of (epi)genetics in gastroenteropancreatic neuroendocrine neoplasms: Moving towards liquid biopsies |
3 |
